Renegade Psych

In this segment, Dr. Gillman tells us about his professional background and what makes him an expert on the subjects of depression and their most appropriate treatments.

If you're passionate about what we do here at Renegade Psych, we're now on Patreon! If you'd like to support our work, you can! Or not... I'll continue putting out content as long as my other jobs pay the bills.  Other things you can do: liking, commenting, and sha...

In this section, Dr. Gillman talks about the origins of Randomized Controlled Trials and illuminates why we should be skeptical of 'so-called' Evidence-Based Medicine.  We also discuss why anecdotal data, or anec-data, aka deriving clinical practice recommendations and guidelines from our own experiences with patients and the drugs we prescribe them, is so important to developing as a good, effective prescribing clinician.

In this segment, Dr. Gillman and I return to the drawing board and discuss on a very fundamental level, what depression is.  We talk about how the concept of and diagnosis of depression has been progressively watered down over the last 50 years, leading to more people being diagnosed and treated with SSRI antidepressants, which have very questionable efficacy and under-reported and under-recognized side effects.

In this segment, I start with a historical monologue on the history of depression and its' treatments throughout human history.  Then, Dr. Gillman explains why it's so important to adequately treat depression with appropriate medications, despite sometimes having to manage a more severe side effect profile.  He argues that the risk/benefit ratio, especially when biologic (vs. neurotic) depression is appropriately identified and dia...

Dr. Gillman gives us some fascinating historical background discussing the emergence of the medical publishing industry and its' relation to Robert Maxwell, the father of Ghislaine Maxwell (confidant of Jeffrey Epstein).  He talks about how decisons are driven by financial incentives and discusses how rating scales and data manipulation runs rampant in all of medicine, but especially in psychiatry, and how research can be very unre...

Dr. Gillman discusses the nuances between diagnosing biologic vs neurotic depression and tells us how to appropriately and effectively treat biologic depression, including his professional push to get more practitioners to utilize MAOIs.

...

This segment doesn't perfectly fit into our broader discussion on Antidepressants, but Dr. Gillman is an internationally-recognized expert in serotonin toxicity, and may be THE MOST expert professional when discussing serotonin toxicity in the world.  It was well-worth the add for this segment that better conceptualizes serotonin overload as a toxicity as opposed to a syndrome.

Here, Dr. Gillman and I summarize our thoughts on our topic of discussion for listeners.  Then, we transition to listening to a song by a local Louisville artist.  We hope you enjoyed this series as well as the song, "Santa Maria," by the band/artist, NOLIA NOON.

This will be a recurring segment where we try to garner a little bit of personal information about our guests, to give listeners a window into who the person behind the professional title is.  Here, Ken talks about his experience with religion and his upbringing, as well as his role in launching 'the last advertisement for Tranylcypromine,' an MAOI medication.  Hope you enjoyed this series on Antidepressants - Going Backwards.

This is a teaser for the release of our next series on Lithium with Dr. Rifaat El-Mallakh.  I'll try to include these at the end of each series so listeners know what's to come.

Thanks for listening.  For more social media content, check...

Here, Michael gives us a little bit of insight into his personal life and hobbies.

Thanks for listening.  For more social media content, check us out on all social media platforms @Renegadepsych. If you have any comments, questions or ch...

These are a few segments pieced together that talk about Sexual Side Effects of psychiatric medications.  We reveal a company that has tried to hijack and market one of the major side effects of SSRI antidepressants as a treatment for premature ejaculation, at the expense of potentially numbing sexual pleasure and sensation for months or even years.  This example of how companies prioritize profit over your well-being is especially...

Join Michael and I for our closing thoughts on the subject of DTCA and Marketing in Healthcare and stick around after for a listen to a local Louisville artist, Jack Rabbit and the Dirty Hares, with their song, 'Wyoming.'

Thanks for list...

Here, we discuss some possible solutions to the problems posed by DTCA and marketing of healthcare, outside of the obvious solution of banning DTCA, which we don't have much faith will happen anytime soon in the United States.

Thanks for...

Join us to discuss some pertinent examples of bad research and problems with the FDA Approval process, especially in mental health and with psychiatric medications.

Thanks for listening.  For more social media content, check us out on al...

Our rant from this series is about the drug Vioxx's scandal from the early 2000s, a drug that has been implicated as contributing to hundreds of thousands of deaths and disabilities, and one in which Merck prioritized profits over Americans' health outcomes.

In this segment, we discuss what DTCA is, different types of pharmaceutical ads, and the role of marketing in the American, and New Zealand's, healthcare system, the only two countries in the world where DTCA of pharmaceutical products is legal.

Here, we reveal some of the actual clinical trial data about Aducanumab and Lecanamab, two Alzheimer's drugs that lowered the bar of FDA approval to an all-time low, revealing an absolute disregard for safety and efficacy of novel drugs and their potential negative impact on the American public.

We discuss the historical transition from before DTCA to its emergence in the 1980s, and subsequent legislation that allowed it to flourish in the mid-to-late 1990s.

Thanks for listening.  For more social media content, check us out on a...